Company / Tangible Book Value per Share
NovoCure Ltd Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.14
FY2025
5-year range
$2.13 / $4.58
FY2021-FY2025
Trend
-6.7%
vs FY2024
Sector context
#98 of 158
Health Care
What the data says
At $3.14, NovoCure Ltd's tangible book value per share ranks #98 of 158 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $4.58 in FY2022 to $3.14 in FY2025.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of +22.7%.
Declined from $3.45 to $3.14 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- +22.7%
- 10-Year CAGR
- -
Sector benchmark
#98 of 158 in Health CareTop 62% of 158This company $3.14 Sector average $18.47
▼
-83.0% below sector average
Key checks
Key Insights
- NovoCure Ltd's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 6.7% year-over-year.
- Ranks #98 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | -6.7% |
| FY2024 | $3.36 | -2.5% |
| FY2023 | $3.45 | -24.7% |
| FY2022 | $4.58 | +115.4% |
| FY2021 | $2.13 | +88.7% |
| FY2020 | $1.13 | -7.4% |
| FY2019 | $1.22 | -23.4% |
| FY2018 | $1.59 | -44.8% |
| FY2017 | $2.88 | +146.6% |
| FY2016 | $1.17 | -90.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026